US Patent Issued to BEIGENE on April 22 for "Imidazo[2,1-f[1,2,4triazin-4-amine derivatives as TLR7 agonist" (Chinese Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,119, issued on April 22, was assigned to BEIGENE LTD. (Grand Cayman, Cayman Islands).

"Imidazo[2,1-f[1,2,4triazin-4-amine derivatives as TLR7 agonist" was invented by Guoliang Zhang (Beijing), Jianzhuang Miao (Beijing), Changyou Zhou (Beijing), Gang Chen (Beijing) and Jing Li (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is an imidazo [2, 1-f] [1, 2, 4] triazin-4-amine derivative or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof useful as a TLR7 agonist, and a pharmaceutical composition comprising the same. Also disclosed herein is a method of treating cancer using the imidazo [2, 1-f] [1, 2, 4] triaz...